Fasenra Pediatric Japan Post-Marketing Study(PMS)

Trial Identifier: D3250C00100
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: December 2028
Study Completion Date: December 2028
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Chiba, Japan
Japan Hiroshima, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Kumamoto, Japan
Japan Mie, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Saitama, Japan